Bieke Decaesteker

Journal Article
A1
open access

SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry

Bieke Decaesteker (UGent) , Amber Louwagie (UGent) , Siebe Loontiens (UGent) , Fanny De Vloed (UGent) , Sarah-Lee Bekaert (UGent) , Juliette Roels (UGent) , Suzanne Vanhauwaert (UGent) , Sara De Brouwer (UGent) , Ellen Sanders, A Berezovskaya, et al.

(2023) NATURE COMMUNICATIONS. 14.

Add to list

Journal Article
A1
open access

RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

Carolina de Carvalho Nunes (UGent) , Lisa Depestel (UGent) , Liselot Mus (UGent) , Kaylee M. Keller, Louis Delhaye (UGent) , Amber Louwagie (UGent) , Muhammad Rishfi (UGent) , Alex Whale, Neesha Kara, Simon R. Andrews, et al.

(2022) SCIENCE ADVANCES. 8(28).

Add to list

The adrenergic-specific long non-coding RNA NESPR controls survival of neuroblastoma cells

Louis Delhaye (UGent) , Eric de Bony de Lavergne (UGent) , Dries Rombaut, Lim Fang Qi, Bieke Decaesteker (UGent) , Lisa Depestel (UGent) , Amber Louwagie (UGent) , Eva D'haene (UGent) , Pieter-Jan Volders (UGent) , Nurten Yigit (UGent) , et al.

(2022) OncoPoint Symposium 2022, Abstracts.

Add to list

RRM2 enhances MYCN driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

Lisa Depestel (UGent) , Carolina de Carvalho Nunes (UGent) , Liselot Mus (UGent) , Iris Nelen (UGent) , Louis Delhaye (UGent) , Kaylee Keller, Volodimir Olexiouk, Fanny De Vloed (UGent) , Ellen Sanders (UGent) , Aline Eggermont (UGent) , et al.

(2022) OncoPoint Symposium 2022, Abstracts.

Add to list

Cellular senescence in neuroblastoma

Sofia Zanotti (UGent) , Bieke Decaesteker (UGent) , Suzanne Vanhauwaert (UGent) , Bram De Wilde (UGent) , Winnok De Vos and Franki Speleman (UGent)

(2022) BRITISH JOURNAL OF CANCER. 126(11). p.1529-1538

Add to list

Journal Article
A1
open access

From DNA copy number gains and tumor dependencies to novel therapeutic targets for high-risk neuroblastoma

Bieke Decaesteker (UGent) , Kaat Durinck (UGent) , Nadine Van Roy (UGent) , Bram De Wilde (UGent) , Christophe Van Neste (UGent) , Stéphane Van Haver (UGent) , Stephen Roberts, Katleen De Preter (UGent) , Vanessa Vermeirssen (UGent) and Franki Speleman (UGent)

(2021) JOURNAL OF PERSONALIZED MEDICINE. 11(12).

Add to list

Journal Article
A1
open access

MEIS2 is an adrenergic core regulatory transcription factor involved in early initiation of TH-MYCN-driven neuroblastoma formation

Jolien De Wyn, Mark W. Zimmerman, Nina Weichert-Leahey, Carolina de Carvalho Nunes (UGent) , Belamy B. Cheung, Brian J. Abraham, Anneleen Beckers (UGent) , Pieter-Jan Volders (UGent) , Bieke Decaesteker (UGent) , Daniel R. Carter, et al.

(2021) CANCERS. 13(19).

Add to list

Journal Article
A1
open access

MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cells

Sofia Zanotti (UGent) , Suzanne Vanhauwaert (UGent) , Christophe Van Neste (UGent) , Volodimir Olexiouk (UGent) , Jolien Van Laere (UGent) , Marlies Verschuuren, Joni Van der Meulen (UGent) , Liselot Mus (UGent) , Kaat Durinck (UGent) , Laurentijn Tilleman (UGent) , et al.

(2021) SCIENTIFIC REPORTS. 11(1).

Add to list

SOX11 as guardian of epigenetic plasticity in neuroblastoma

Bieke Decaesteker (UGent) , Amber Louwagie (UGent) , Siebe Loontiens (UGent) , Sara De Brouwer, Carolina de Carvalho Nunes (UGent) , Geertrui Denecker, Fanny De Vloed (UGent) , Lisa Depestel (UGent) , Juliette Roels (UGent) , Karen Verboom, et al.

(2021) Advances in Neuroblastoma Research (ANR 2021), Abstracts.

Add to list

Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma

Elena A Afanasyeva, Moritz Gartlgruber, Tatsiana Ryl, Bieke Decaesteker (UGent) , Geertrui Denecker, Gregor Mönke, Umut H Toprak, Andres Florez, Alica Torkov, Daniel Dreidax, et al.

(2021) LIFE SCIENCE ALLIANCE. 4(5).

Academic Bibliography

Bieke Decaesteker

SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry

RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

The adrenergic-specific long non-coding RNA NESPR controls survival of neuroblastoma cells

RRM2 enhances MYCN driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition

Cellular senescence in neuroblastoma

From DNA copy number gains and tumor dependencies to novel therapeutic targets for high-risk neuroblastoma

MEIS2 is an adrenergic core regulatory transcription factor involved in early initiation of TH-MYCN-driven neuroblastoma formation

MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cells

SOX11 as guardian of epigenetic plasticity in neuroblastoma

Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma

Contents

Support

Contact